US pharma major Eli Lilly to invest $1 billion in Telangana

US pharma major Eli Lilly will invest $1 billion in Telangana to expand its manufacturing and global medicine supply capacity, the state government said on Monday.

The announcement followed a meeting between a global delegation from the company and Telangana Chief Minister A Revanth Reddy and Industries Minister D Sridhar Babu in Hyderabad.

"Telangana secured a massive investment of USD 1 bn by US Pharma major Eli Lilly, which will expand its manufacturing and global medicine supply capacity in Hyderabad," an official release said.

As part of the plan, the company will set up a new hub in Hyderabad to provide advanced technical capabilities and oversee Lilly’s contract manufacturing operations across India.

Recruitment for the new facility will begin immediately, covering roles such as engineers, chemists, analytical scientists, quality assurance professionals, and management positions, the US-headquartered company said in a statement.

"Working with trusted contract manufacturers expands our capabilities to deliver life-changing medicines at greater scale -- with quality always at the core. This investment reaffirms our confidence in India as a hub for capability building within our global network," said Patrik Jonsson, Executive Vice President and President Lilly International, Eli Lilly and Company.

Since 2020, Lilly has committed more than $55 billion to building, expanding, and acquiring facilities in the US and around the world.

The company has a long-standing presence in India, including a commercial site in Gurugram and specialised sites in Bengaluru and Hyderabad that serve as essential hubs supporting global innovation.

"Lilly's continued expansion in Hyderabad highlights the city's emergence as a powerhouse in global healthcare innovation," Revanth Reddy said.